HIV-1 infection and cognitive impairment in the cART era: a review
- 13 March 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 25 (5), 561-575
- https://doi.org/10.1097/qad.0b013e3283437f9a
Abstract
With the introduction of combination antiretroviral therapy AIDS dementia complex or HIV-associated dementia, as it was termed later, largely disappeared in clinical practice. However, in the past few years, patients, long-term infected and treated, including those with systemically well controlled infection, started to complain about milder memory problems and slowness, difficulties in concentration, planning, and multitasking. Neuropsychological studies have confirmed that cognitive impairment occurs in a substantial (15-50%) proportion of patients. Among HIV-1-infected patients cognitive impairment was and is one of the most feared complications of HIV-1 infection. In addition, neurocognitive impairment may affect adherence to treatment and ultimately result in increased morbidity for systemic disease. So what may be going on in the CNS after so many years of apparently controlled HIV-1 infection is an urgent and important challenge in the field of HIV medicine. In this review we summarize the key currently available data. We describe the clinical neurological and neuropsychological findings, the preferred diagnostic approach with new imaging techniques and cerebrospinal fluid analysis. We try to integrate data on pathogenesis and finally discuss possible therapeutic interventionKeywords
This publication has 187 references indexed in Scilit:
- Food Combination and Alzheimer Disease RiskArchives of Neurology, 2010
- Cognitive Neuropsychology of HIV-Associated Neurocognitive DisordersNeuropsychology Review, 2009
- Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive DisordersJournal of Neuroimmune Pharmacology, 2009
- Declined neural efficiency in cognitively stable human immunodeficiency virus patientsAnnals of Neurology, 2009
- Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapyJournal of Allergy and Clinical Immunology, 2009
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- CSF proteomic fingerprints for HIV-associated cognitive impairmentJournal of Neuroimmunology, 2007
- 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometryNeuroImage, 2007
- The neuropathogenesis of AIDSNature Reviews Immunology, 2005
- AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlationsAnnals of Neurology, 1995